Welcome to the 2019 Cure Symposium

The Future of Psoriatic Disease: Prevention, Precision Medicine and Cure
May 30-31, 2019
Hyatt Regency | Seattle, WA

Help shape the future of psoriatic disease! Join us May 30-31, 2019 for a special symposium hosted by the National Psoriasis Foundation.

Symposium Goal

The 2019 NPF Future of Psoriatic Disease Symposium will inaugurate a new NPF effort to develop a scientific roadmap to achieve prevention, precision medicine, and a cure for psoriatic diseases. Psoriatic disease is a heterogeneous immune-mediated disease affecting the skin, the joints, and other organ systems. The meeting will provide a venue for education, dissemination of scientific results, and collaboration between clinicians and scientists to advance new discoveries.

Keynote Address

"Immunologic Insights into Psoriasis"
Rachael A. Clark, M.D., Ph.D.
Dept. of Dermatology, Brigham and Women's Hospital
Harvard Medical School

Dr. Clark is the Shing Yu Yip and Cecelia B. Hepp Associate Professor of Dermatology at Harvard Medical School and one of the world’s leading experts on the role of resident memory T cells in health and disease. Her research has led to new insights about the role of resident memory T cells in psoriasis and skin cancer and may open up new therapeutic avenues for the treatment of these diseases.

Planning Committee

Wilson Liao, MD, University of California, San Francisco (Co-Chair)
Johann Gudjonsson, MD, PhD, University of Michigan, Ann Arbor (Co-Chair)
Lawrence Green, MD, George Washington University School of Medicine
Leon Kircik, MD, Icahn School of Medicine at Mount Sinai
Joseph Markenson, MD, Hospital for Special Surgery
Philip Mease, MD, Swedish Providence Health Systems, Seattle
Christopher Ritchlin, MD, MPH, University of Rochester
Jose Scher, MD, NYU Langone Health
Abby Van Voorhees, MD, Eastern Virginia School of Medicine
Nicole Ward, PhD, Case Western Reserve University

Important Dates

  • December 3, 2018 - Registration opens
  • April 5, 2019 - Last day to submit an abstract
  • April 5, 2019 - Travel Grant application deadline
  • May 17, 2019 - Last day to register!

Learning Objectives

  1. Provide a forum for leading experts in psoriatic disease research and clinical care to educate participants on cutting-edge topics.
  2. Discuss results from ongoing research projects.
  3. Foster collaboration through targeted discussion around the best ways to move the field forward while making best use of the resources that NPF can provide.

Accreditation Statement

The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The National Psoriasis Foundation designates this live activity for a maximum of 9.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This program is supported by educational grants from Lilly, Ortho Dermatologics, Pfizer and UCB.

Please contact Susan Hardin, Medical Programs Manager, with any questions at [email protected]